Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3835 for Cellulite
NCT02724644Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Feb 2016
- Primary completion
- Sep 2016
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cellulite comparing EN3835 Active with EN3835 Placebo (2 arms). Primary endpoint: Percentage of Composite Responders of at Least 2-Level Improvement of Severity at Day 71. Started Feb 2016; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT02724644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724644.